These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34718049)

  • 1. Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis.
    Ueno F; Iwata Y; Nakajima S; Caravaggio F; Rubio JM; Horga G; Cassidy CM; Torres-Carmona E; de Luca V; Tsugawa S; Honda S; Moriguchi S; Noda Y; Gerretsen P; Graff-Guerrero A
    Neurosci Biobehav Rev; 2022 Jan; 132():1205-1213. PubMed ID: 34718049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.
    Cassidy CM; Carpenter KM; Konova AB; Cheung V; Grassetti A; Zecca L; Abi-Dargham A; Martinez D; Horga G
    Am J Psychiatry; 2020 Nov; 177(11):1038-1047. PubMed ID: 32854531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.
    Cassidy CM; Zucca FA; Girgis RR; Baker SC; Weinstein JJ; Sharp ME; Bellei C; Valmadre A; Vanegas N; Kegeles LS; Brucato G; Kang UJ; Sulzer D; Zecca L; Abi-Dargham A; Horga G
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5108-5117. PubMed ID: 30796187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
    van der Pluijm M; Wengler K; Reijers PN; Cassidy CM; Tjong Tjin Joe K; de Peuter OR; Horga G; Booij J; de Haan L; van de Giessen E
    Am J Psychiatry; 2024 Jun; 181(6):512-519. PubMed ID: 38476044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and voxelwise analyses.
    Wengler K; He X; Abi-Dargham A; Horga G
    Neuroimage; 2020 Mar; 208():116457. PubMed ID: 31841683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.
    Leitão R; Guerreiro C; Nunes RG; Gonçalves N; Galati G; Rosário M; Guedes LC; Ferreira JJ; Reimão S
    J Huntingtons Dis; 2020; 9(2):143-148. PubMed ID: 32065802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.
    Watanabe Y; Tanaka H; Tsukabe A; Kunitomi Y; Nishizawa M; Hashimoto R; Yamamori H; Fujimoto M; Fukunaga M; Tomiyama N
    PLoS One; 2014; 9(8):e104619. PubMed ID: 25111500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of a high-spatial-resolution voxelwise analysis of neuromelanin-sensitive imaging in early-stage idiopathic Parkinson's disease.
    Seong M; Park S; Sung YH; Kim EY
    BMC Med Imaging; 2023 May; 23(1):64. PubMed ID: 37202720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized Data Acquisition for Neuromelanin-sensitive Magnetic Resonance Imaging of the Substantia Nigra.
    Salzman G; Kim J; Horga G; Wengler K
    J Vis Exp; 2021 Sep; (175):. PubMed ID: 34570093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromelanin levels in individuals with substance use disorders: A systematic review and meta-analysis.
    Ahrens J; Zaher F; Rabin RA; Cassidy CM; Palaniyappan L
    Neurosci Biobehav Rev; 2024 Jun; 161():105690. PubMed ID: 38678736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra.
    Liu XL; Yang LQ; Liu FT; Wu PY; Zhang Y; Zhuang H; Shi YH; Wang J; Geng DY; Li YX
    BMC Neurol; 2020 Jun; 20(1):262. PubMed ID: 32605601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report.
    Ishikuro K; Hattori N; Imanishi R; Furuya K; Nakata T; Dougu N; Yamamoto M; Konishi H; Nukui T; Hayashi T; Anada R; Matsuda N; Hirosawa H; Tanaka R; Shibata T; Mori K; Noguchi K; Kuroda S; Nakatsuji Y; Nishijo H
    Neurocase; 2021 Oct; 27(5):407-414. PubMed ID: 34503372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromelanin-sensitive magnetic resonance imaging in the study of mental disorder: A systematic review.
    Lv Q; Wang X; Lin P; Wang X
    Psychiatry Res Neuroimaging; 2024 Apr; 339():111785. PubMed ID: 38325165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Scanner Harmonization of Neuromelanin-Sensitive MRI for Multisite Studies.
    Wengler K; Cassidy C; van der Pluijm M; Weinstein JJ; Abi-Dargham A; van de Giessen E; Horga G
    J Magn Reson Imaging; 2021 Oct; 54(4):1189-1199. PubMed ID: 33960063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D
    Ito H; Kawaguchi H; Kodaka F; Takuwa H; Ikoma Y; Shimada H; Kimura Y; Seki C; Kubo H; Ishii S; Takano H; Suhara T
    Neuroimage; 2017 Sep; 158():12-17. PubMed ID: 28655632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function.
    Trujillo P; Aumann MA; Claassen DO
    Brain; 2024 Feb; 147(2):337-351. PubMed ID: 37669320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging-based brain template.
    Jin Z; Wang Y; Jokar M; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Zhang Y; Min J; Liu F; He N; Yan F; Haacke EM
    Hum Brain Mapp; 2022 Apr; 43(6):2011-2025. PubMed ID: 35072301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.